相关实验视频

Updated: Jun 24, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

扩散型大B细胞淋巴瘤中的线粒体相关特征:预后,免疫和治疗特征

Zhen-Zhong Zhou^1,2, Jia-Chen Lu^1,2, Song-Bin Guo^1,2

¹Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.

Cancer medicine

|January 15, 2025

概括

这项研究确定了18个预后性线粒体相关基因,以创建扩散大B细胞淋巴瘤 (DLBCL) 的风险模型. 该模型预测了DLBCL患者的患者存活率,免疫微环境和治疗反应.

科学领域:

在瘤学瘤学.
遗传学遗传学是一个
生物信息学是一种生物信息学.

背景情况:

扩散性大B细胞淋巴瘤 (DLBCL) 呈现出显著的异质性.
线粒体在癌症的发展和进展中起着至关重要的作用,特别是在DLBCL中.

研究的目的:

在DLBCL中确定预后性线粒体相关基因 (MRG).
使用MRG和机器学习开发DLBCL的预测风险模型.

主要方法:

利用了基因表达综合 (GEO) 数据库中的转录组资料和临床数据.
采用最小绝对收缩和选择操作员 (Lasso) 回归来构建一个风险模型,在独立的数据集上进行验证.
将患者分为两层,分为风险组,生成名图,并比较基因路径,微环境和组之间的治疗反应.

主要成果:

确定了18个预后MRG来构建风险模型.
高风险组的整体存活率较低,免疫透率降低,CD20较低,PD-L1表达率较高.
风险组之间在免疫微环境,免疫疗法反应和药物敏感性方面观察到显著差异.

结论:

使用机器学习开发了一种基于线粒体相关基因的新型预后签名.
签名有效地预测瘤微环境特征和DLBCL中的治疗反应.

关键词:

扩散的大B细胞淋巴瘤药物敏感性药物敏感性基因组丰富分析分析免疫环境免疫环境与线粒体相关的基因预测模型的预测模型.

更多相关视频

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...